Earnings Call Intelligence Subscribe
Home › Call Sheets › ZTS › Q4'25
Call sheet · Q4'25

Zoetis (ZTS)

Q4'25 earnings call · held February 12, 2026 · compared with the Q3'25 call · management-credibility review
8/12
Disclosure score
4 medium, 2 low flags
Financial quality
Bottom line
The market is missing that ZTS just pre-announced margin pressure by disclosing manufacturing costs offset their price gains, while using fiscal timing games to goose international growth by 350bps. Everyone will focus on the 3-5% 2026 guidance being below their historical range, but the real story is margin quality deterioration hidden by the MFA divestiture mix benefit. Librela's 'stabilization' at a $205M run rate versus its $330M peak means their OA pain franchise math doesn't work - Lanivia will cannibalize their own recovery. The binding constraint isn't demand or competition, it's that they're fighting themselves across multiple franchises while manufacturing costs eat margins. Kristin's admission that 'we will cannibalize some of Librela' with Lanivia captures the innovation trap perfectly. My view changes if they can show manufacturing cost relief and quantify the exact cannibalization rate for their OA portfolio.

The 30-second version

  • The sleeper story: $1.75B share buyback funded by converts is masking margin pressure from manufacturing costs eating full-year gross margin expansion
  • Librela bottomed but recovery math doesn't work: 'stabilizing' at $205M run rate vs $330M peak means they need Lanivia to cannibalize their own recovery
  • International segment got a 2.5-3.5% revenue boost from fiscal year alignment games, making organic growth look better than reality

What changed this quarter

MetricQ3'25Q4'25Change
Revenue$2.4B (+1% reported, +4% organic operational)$2.4B (+3% reported, +4% organic operational)Flat organic growth, timing benefits masked reality
Adjusted Net Income$754M (+5% reported, +9% organic operational)$648M (+3% reported, +4% organic operational)500bps deceleration in organic growth
U.S. Companion AnimalFlat organic operational-1% organic operationalFirst decline in years, macro headwinds hit
International Revenue+6% organic operational+7% organic operationalInflated by 250-350bps from fiscal timing games
Simparica Franchise Global+7% operational+3% operational400bps deceleration despite easier comp
Key Dermatology Global+3% operational+1% operational200bps deceleration, competitive pressure mounting
OA Pain Franchise-11% operational-11% operationalNo sequential improvement despite 'stabilization' claims
Livestock Revenue+10% organic operational+9% organic operationalStill strong but losing steam
Adjusted Gross Margin71.6%71.9%+30bps but manufacturing cost headwinds visible
2026 Revenue GuidanceNot provided$9.825B to $10.025B (+3% to +5% organic operational)Below historical 6-8% range, acknowledging reality

Accountability tracked

8 new promises made6 narrative shifts flagged8 prior promises scored
Inside the full report
The complete write-up covers the full promise ledger with kept/missed calls, disclosure-quality scoring, the metrics-vanished check, verification items, and the questions to ask next quarter.
Read the full ZTS Q4'25 report Subscribe
About Research ↗Call SheetsCredibility IndexMissed PromisesScreens13F BooksData & InstitutionalPrivacyTermsSubscribe
This is a free preview. The full write-up and promise ledger are published to subscribers on Substack.
Scores, kept-promise rates, and flags on this site reflect the author's opinion, applying a stated methodology to statements management made on public earnings calls. Informational and educational purposes only - not investment advice, a recommendation, or an offer to buy or sell any security. Sources believed reliable but not guaranteed; the author may hold positions in the securities discussed.

Follow what management promises next

Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.

Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.